Atlas Trials

Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea

Clinical trial NCT03761134 · TERMINATED

Trial details

NCT number
NCT03761134
Sponsor
Sanofi
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2018-11-30
Primary completion
2020-04-29
Enrollment
377

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.